{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:07:47Z","timestamp":1790798867773,"version":"4.1.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.abd.2023.07.018","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T15:43:19Z","timestamp":1718293399000},"page":"775-777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of bullous pemphigoid and Grover disease induced by immune checkpoint therapy"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1075-5103","authenticated-orcid":false,"given":"Elena Luc\u00eda","family":"Pinto-Pulido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9353-4367","authenticated-orcid":false,"given":"Isabel","family":"Polo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8330-4215","authenticated-orcid":false,"given":"Marta","family":"Gonz\u00e1lez-Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1850-2397","authenticated-orcid":false,"given":"Ileana","family":"Medina-Exp\u00f3sito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2659-2676","authenticated-orcid":false,"given":"Mar\u00eda Dolores","family":"V\u00e9lez-Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3165-5387","authenticated-orcid":false,"given":"Susana","family":"Medina-Montalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2023.07.018_bib0005","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bjd.21781","article-title":"Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients","volume":"187","author":"Nikolaou","year":"2022","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.07.018_bib0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/jdv.17855","article-title":"European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events","volume":"36","author":"Apalla","year":"2022","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2023.07.018_bib0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2021.03.094","article-title":"Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: a United States population-level analysis","volume":"86","author":"Wongvibulsin","year":"2022","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2023.07.018_bib0020","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1111\/ijd.16068","article-title":"Bullous pemphigoid associated with Grover disease: a specific toxicity of anti-PD-1 therapies?","volume":"61","author":"Jendoubi","year":"2022","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2023.07.018_bib0025","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/cup.14383","article-title":"Concomitant nivolumab associated Grover disease and bullous pemphigoid in a patient with metastatic renal cell carcinoma","volume":"50","author":"Khazaeli","year":"2023","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.abd.2023.07.018_bib0030","doi-asserted-by":"crossref","first-page":"515","DOI":"10.23736\/S0392-0488.18.06066-2","article-title":"Bullous pemphigoid as a further association in extensive cases of Grover disease","volume":"155","author":"Donati","year":"2020","journal-title":"G Ital Dermatol Venereol."},{"key":"10.1016\/j.abd.2023.07.018_bib0035","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/ced.13789","article-title":"Grover disease and bullous pemphigoid: a clinicopathological study of six cases","volume":"44","author":"Ellenbogen","year":"2019","journal-title":"Clin Exp Dermatol."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059624001223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059624001223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:51Z","timestamp":1747666851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059624001223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0365059624001223"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2023.07.018","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of bullous pemphigoid and Grover disease induced by immune checkpoint therapy","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2023.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}